Taking people in United StatesPhase 3
Travoprost Implant Placed Inside the Eye for People With Glaucoma
Tests a second generation travoprost implant in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Key facts
- Where
- Dothan, United StatesSee the site
- Phase
- Phase 3
Where in United States
- DothanDothan, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT07495852
- Record updated
- 30 March 2026
- Original description
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRead full original descriptionShow less
Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Inclusion: Diagnosis of Ocular Hypertension or Open-Angle Glaucoma in the study eye.
Exclusion: Prior incisional glaucoma surgery in the study eye; Prior minimally invasive glaucoma (MIGS) surgery in the study eye; Prior argon laser trabeculoplasty (ALT) in the study eye.